Month: August 2025

Transforming Parkinson’s disease treatment, Insilico Medicine announces IND-enabling completion for AI-empowered oral NLRP3 inhibitor ISM8969

image: ISM8969 dose dependently improved behavioral performance in open field, rotarod and grip strength tests in MPTP induced Parkinson disease (PD)...